These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 28478430)
1. The impact of the legal regime of intellectual property protection in the pharmaceutical market. Pashkov VM; Golovanova IA; Olefir AA Wiad Lek; 2016; 69(3 pt 2):582-586. PubMed ID: 28478430 [TBL] [Abstract][Full Text] [Related]
2. The impact of the legal regime of intellectual property protection in the pharmaceutical market. Pashkov VM; Golovanova IA; Olefir AA Wiad Lek; 2016; 69(3 pt 2):582-586. PubMed ID: 27717949 [TBL] [Abstract][Full Text] [Related]
3. What is the impact of intellectual property rules on access to medicines? A systematic review. Tenni B; Moir HVJ; Townsend B; Kilic B; Farrell AM; Keegel T; Gleeson D Global Health; 2022 Apr; 18(1):40. PubMed ID: 35428250 [TBL] [Abstract][Full Text] [Related]
4. Trade-Related Aspects of Intellectual Property Rights Flexibilities and Public Health: Implementation of Compulsory Licensing Provisions into National Patent Legislation. McGIVERN L Milbank Q; 2023 Dec; 101(4):1280-1303. PubMed ID: 37646392 [TBL] [Abstract][Full Text] [Related]
5. Raising the Barriers to Access to Medicines in the Developing World - The Relentless Push for Data Exclusivity. Diependaele L; Cockbain J; Sterckx S Dev World Bioeth; 2017 Apr; 17(1):11-21. PubMed ID: 26818105 [TBL] [Abstract][Full Text] [Related]
6. Impact of the trade-related aspects of intellectual property rights (TRIPS) agreement on India as a supplier of generic antiretrovirals. Babovic S; Wasan KM J Pharm Sci; 2011 Mar; 100(3):816-21. PubMed ID: 20740678 [TBL] [Abstract][Full Text] [Related]
7. Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001-2016. 't Hoen EF; Veraldi J; Toebes B; Hogerzeil HV Bull World Health Organ; 2018 Mar; 96(3):185-193. PubMed ID: 29531417 [TBL] [Abstract][Full Text] [Related]
8. [Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines]. Chaves GC; Oliveira MA; Hasenclever L; de Melo LM Cad Saude Publica; 2007 Feb; 23(2):257-67. PubMed ID: 17221075 [TBL] [Abstract][Full Text] [Related]
9. Protecting the rights of producers original medicines. Pashkov V; Kotvitska A; Noha P Wiad Lek; 2017; 70(4):834-837. PubMed ID: 29064813 [TBL] [Abstract][Full Text] [Related]
10. Trade, TRIPS, and pharmaceuticals. Smith RD; Correa C; Oh C Lancet; 2009 Feb; 373(9664):684-91. PubMed ID: 19167054 [TBL] [Abstract][Full Text] [Related]
11. Asserting the primacy of health over patent rights: a comparative study of the processes that led to the use of compulsory licensing in Thailand and Brazil. Rosenberg ST Dev World Bioeth; 2014 Aug; 14(2):83-91. PubMed ID: 24750542 [TBL] [Abstract][Full Text] [Related]
12. Changes to intellectual property policy in South Africa: putting a stop to evergreening? Hill JE Expert Opin Ther Pat; 2014 Aug; 24(8):839-43. PubMed ID: 24965317 [TBL] [Abstract][Full Text] [Related]
13. The role of intellectual property rights on access to medicines in the WHO African region: 25 years after the TRIPS agreement. Motari M; Nikiema JB; Kasilo OMJ; Kniazkov S; Loua A; Sougou A; Tumusiime P BMC Public Health; 2021 Mar; 21(1):490. PubMed ID: 33706726 [TBL] [Abstract][Full Text] [Related]
14. The Effects of Intellectual Property Rights on Access to Medicines and Catastrophic Expenditure. Jung Y; Kwon S Int J Health Serv; 2015; 45(3):507-29. PubMed ID: 26077858 [TBL] [Abstract][Full Text] [Related]
15. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health? Oliveira MA; Bermudez JA; Chaves GC; Velásquez G Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916 [TBL] [Abstract][Full Text] [Related]
16. Patent implications in the pharmaceutical industry: Are static high prices leading to dynamic innovations? Pandey E; Paul SB Int J Risk Saf Med; 2019; 30(3):179-192. PubMed ID: 31450515 [TBL] [Abstract][Full Text] [Related]
17. The ethics of intellectual property rights in an era of globalization. Shah AK; Warsh J; Kesselheim AS J Law Med Ethics; 2013; 41(4):841-51, Table of Contents. PubMed ID: 24446942 [TBL] [Abstract][Full Text] [Related]
18. Intellectual property rights, market competition and access to affordable antiretrovirals. Pascual F Antivir Ther; 2014; 19 Suppl 3():57-67. PubMed ID: 25309984 [TBL] [Abstract][Full Text] [Related]
19. The pharmaceutical industry as a medicines provider. Henry D; Lexchin J Lancet; 2002 Nov; 360(9345):1590-5. PubMed ID: 12443614 [TBL] [Abstract][Full Text] [Related]